Cite
MLA Citation
M. Yu et al.. “IDF21-0036 Patient-Reported Outcomes in Patients with Type 2 Diabetes Treated with Tirzepatide or Insulin Degludec (SURPASS-3).” Diabetes research and clinical practice, vol. 186, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100156434694.0x000043